产品编号 | CFN60054 | |
CAS编号 | 877399-52-5 | |
分子式 = 分子量 | C21H22Cl2FN5O = 450.34 | |
产品纯度 | >=98% | |
物理属性 | Powder | |
化合物类型 | Alkaloids | |
植物来源 | ||
ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 |
产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
克唑替尼 | CFN60054 | 877399-52-5 | 1mg | QQ客服:2056216494 |
克唑替尼 | CFN60054 | 877399-52-5 | 5mg | QQ客服:2056216494 |
克唑替尼 | CFN60054 | 877399-52-5 | 10mg | QQ客服:2056216494 |
克唑替尼 | CFN60054 | 877399-52-5 | 20mg | QQ客服:2056216494 |
Description: | Crizotinib (PF-02341066) is a potent inhibitor of c-Met and ALK with IC50 of 11 nM and 24 nM in cell-based assays, respectively. It is also a potent ROS1 inhibitor with Ki value less than 0.025 nM. Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines. |
Targets: | c-Met | ALK | ROS1 | Autophagy | STAT3 |
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.2205 mL | 11.1027 mL | 22.2054 mL | 44.4109 mL | 55.5136 mL |
5 mM | 0.4441 mL | 2.2205 mL | 4.4411 mL | 8.8822 mL | 11.1027 mL |
10 mM | 0.2221 mL | 1.1103 mL | 2.2205 mL | 4.4411 mL | 5.5514 mL |
50 mM | 0.0444 mL | 0.2221 mL | 0.4441 mL | 0.8882 mL | 1.1103 mL |
100 mM | 0.0222 mL | 0.111 mL | 0.2221 mL | 0.4441 mL | 0.5551 mL |
产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
Platycoside K; Platycoside K | CFN92271 | 899447-64-4 | C42H68O17 = 845.0 | 5mg | QQ客服:3257982914 |
3,4',7-三乙酰山奈酚; 3,4',7-三乙酸堪非醇酯; Kaempferol 3,4,7-triacetate | CFN99479 | 143724-69-0 | C21H16O9 = 412.4 | 5mg | QQ客服:2056216494 |
Cimiracemoside F; Cimiracemoside F | CFN70324 | 264875-61-8 | C37H56O11 = 676.9 | 5mg | QQ客服:3257982914 |
Rubranol; Rubranol | CFN98060 | 211126-61-3 | C19H24O5 = 332.4 | 5mg | QQ客服:3257982914 |